Preview

Неврология, нейропсихиатрия, психосоматика

Расширенный поиск

Влияние антиэпилептических препаратов на когнитивные функции

https://doi.org/10.14412/2074-2711-2013-2489

Полный текст:

Аннотация

Нарушение когнитивных функций – частая проблема у пациентов с эпилепсией. Точная причина нарушения когнитивных функций при эпилепсии остается неизвестной, однако не вызывает сомнения, что определенную роль в этом играют три фактора: заболевание, лежащее в основе эпилепсии, собственно эпилептические приступы, а также негативные побочные эффекты антиэпилептических препаратов (АЭП). Побочные эффекты АЭП в отношении когнитивных функций являются одной из основных проблем, влияющих на переносимость терапии. В обзоре рассматривается влияние фенобарбитала, фенитоина, карбамазепина, вальпроатов, окскарбазепина, топирамата, ламотриджина и леветирацетама на когнитивные функции здоровых добровольцев и пациентов с эпилепсией.

Об авторе

А. С. Котов
ГБУЗ МО «МОНИКИ им. М.Ф. Владимирского», Москва
Россия


Список литературы

1. <div><p>Aldenkamp A.P., Dodson W.E., eds. Epilepsy and education; cognitive factors in learning behaviour. Epilepsia 1990;31(suppl 4): 9–20.</p><p>Dodson W.E., Pellock J.M. Pediatric Epilepsy: Diagnosis and Treatment. New York: Demos Publications, 1993.</p><p>Aldenkamp A.P., Dreifuss F.E., Renier W.O. et al. Epilepsy in Children and Adolescents. Boca Raton, FL: CRC Press, 1995.</p><p>Aldenkamp A.P. Antiepileptic drug treatment and epileptic seizures–effects on cognitive function. In: M. Trimble, B. Schmitz. (Eds). The Neuropsychiatry of Epilepsy. New York: Cambridge University Press, 2002:256–67.</p><p>Dodrill C.B., Troupin A.S. Psychotropic effects of carbamazepine in epilepsy: a double-blind comparison with phenytoin. Neurology 1977;27:1023–8.</p><p>Ideström C.M., Schalling D., Carlquist U. et al. Acute effects of diphenylhydantoin in relation to plasma levels. Behavioural and psychological studies. Psychol Med 1972;2:111–20.</p><p>Jette N.J., Marson A.G., Hutton J.L. Topiramate add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2002;(3):CD001417.</p><p>Marson A.G., Kadir Z.A., Hutton J.L. et al. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997;38:859–80.</p><p>Aldenkamp A.P. Cognitive and behavioural assessment in clinical trials: when should they be done? Epilepsy Res 2001;45:155–9.</p><p>Aldenkamp A.P., De Krom M., Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia 2003;44(Suppl 4):21–9.</p><p>Vermeulen J., Aldenkamp A.P. Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Res 1995;22:65–95.</p><p>MacLeod C.M., Dekaban A.S., Hunt E. Memory impairment in epileptic patients: selective effects of phenobarbital concentration. Science 1978;202:1102–4.</p><p>Calandre E.P., Dominguez-Granados R., Gomez-Rubio M. et al. Cognitive effects of long-term treatment with phenobarbital and valproic acid in school children. Acta Neur Scand 1990;81:504–6.</p><p>Gallassi R., Morreale A., Di Sarro R. et al. Cognitive effects of antiepileptic drug discontinuation. Epilepsia 1992;33(Suppl 6):41–4.</p><p>Meador K.J., Loring D.W., Huh K. et al. Comparative cognitive effects of anticonvulsants. Neurology 1990;40:391–4.</p><p>Vining E.P., Mellitis E.D., Dorsen M.M. et al. Psychologic and behavioural effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid. Pediatrics 1987;80(2):165–74.</p><p>Meador K.J., Loring D.W., Moore E.E. et al. Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults. Neurology 1995;45(8):1494–9.</p><p>Meador K.J., Loring D.W., Abney O.L. et al. Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia 1993;34(1):153–7.</p><p>Meador K.J., Loring D.W., Allen M.E. et al. Comparative cognitive effects of carbamazepine and phenytoin in healthy adults. Neurology 1991;41:1537–40.</p><p>Smith W.L., Lowrey J.B. Effects of diphenylhydantoin on mental abilities in the elderly. J Am Geriatr Soc 1975;23:207–11.</p><p>Thompson P.J., Huppert F., Trimble M.R. Anticonvulsant drugs, cognitive function and memory. Acta Neurol Scand 1980;80:75–80.</p><p>Thompson P.J., Huppert F.A., Trimble M.R. Phenytoin and cognitive functions: effects on normal volunteers and implications for epilepsy. Br J Clin Psychol 1981;20:155–62.</p><p>Äikiä M., Kälviäinen R., Sivenius J. et al. Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up. Epilepsy Res 1992;11:199–203.</p><p>Forsythe I., Butler R., Berg I. et al. Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate. Dev Med Child Neurol 1991;33:524–34.</p><p>Salinsky M.C., Spencer D., Oken B.S. et al. Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers. Epilepsy Behav 2004;5:894–902.</p><p>Aldenkamp A.P., Alpherts W.C.J., Blennow G. et al. Withdrawal of antiepileptic medication – effects on cognitive function in children: the Multicentre Holmfrid Study. Neurology 1993;43:41–50.</p><p>Craig I., Tallis R. Impact of valproate and phenytoin on cognitive function in elderly patients: results of a single-blind randomized comparative study. Epilepsia 1994;35:381–90.</p><p>Prevey M.L., Delaney R.C., Cramer J.A. et al. Effect of valproate on cognitive function. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group. Arch Neurol 1996;53(10):1008–16.</p><p>Thompson P.J., Trimble M.R. Sodium valproate and cognitive functioning in normal volunteers. Br J Clin Pharmacol 1981;12:819–24.</p><p>Curran H.V., Java R. Memory and psychomotor effects of oxcarbazepine in healthy human volunteers. Eur J Clin Pharmacol 1993;44:529–33.</p><p>Laaksonen R., Kaimola K., Grahn-Teräväinen E. et al. A controlled clinical trial of the effects of carbamazepine and oxcarbazepine on memory and attention [abstract]. 16th International Epilepsy Congress, Hamburg, 1985.</p><p>Sabers A., Moller A., Dam M. et al. Cognitive function and anticonvulsant therapy: effect of monotherapy in epilepsy. Acta Neurol Scand 1995;92:19–27.</p><p>McKee P.J., Blacklaw J., Forrest G. et al. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients. Br J Clin Pharmacol 1994;37:27–32.</p><p>Donati F., Gobbi G., Campistol J. et al. Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures. Neurology 2006;67(4):679–82.</p><p>Privitera M., Fincham R., Penry J. et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1000-mg daily dosages. Topiramate YE Study Group. Neurology 1996;46:1678–83.</p><p>Ketter T.A., Post R.M., Theodore W.H. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology 1999;53(Suppl 2):53–67.</p><p>Tatum W.O., French J.A., Faught E. et al. Postmarketing experience with topiramate and cognition. Epilepsia 2001;42:1134–40.</p><p>Bootsma H.P., Coolen F., Aldenkamp A.P. et al. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Epilepsy Behav 2004;5(3):380–7.</p><p>Martin R., Kuzniecky R., Ho S. et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999;52:321–7.</p><p>Meador K.J. Assessing cognitive effects of a new AED without the bias of practice effects [abstract]. Epilepsia 1997;38(Suppl 3):60(abst).</p><p>Aldenkamp A.P., Baker G., Mulder O.G. et al. A multicentre randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 2000;41:1167–78.</p><p>Burton L.A., Harden C. Effect of topiramate on attention. Epilepsy Res 1997;27:29–32.</p><p>Thompson P.J., Baxendale S.A., Duncan J.S. et al. Effects of topiramate on cognitive function. J Neurol Neurosurg Psychiatry 2000;69:636–41.</p><p>Kockelmann E., Elger C.E., Hemstaedter C. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication. Epilepsy Behav 2004;5:716–21.</p><p>Cohen A.F., Ashby L., Crowley D. et al. Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam. Br J Clin Pharmacol 1985;20:619–29.</p><p>Hamilton M.J., Cohen A.F., Yuen A.W. et al. Carbamazepine and lamotrigine in healthy volunteers: relevance to early tolerance and clinical trial dosage. Epilepsia1993;34:166–73.</p><p>Meador K.J., Loring D.W., Ray P.G. et al. Differential effects of carbamazepine and lamotrigine [abstract]. Neurology 2000;54(Suppl 3):84(abst).</p><p>Aldenkamp A.P., Arends J., Bootsma H.P. et al. Randomized, double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers. Epilepsia 2002;43:19–26.</p><p>Gillham R., Kane K., Bryant-Comstock L. et al. A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure. Seizure 2000;9:375–9.</p><p>Banks G.K., Beran R.G. Neuropsychological assessment in lamotrigine treated epileptic patients. Clin Exp Neurol 1991;28:230–7.</p><p>Smith D., Baker G., Davies G. et al. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993;34:312–22.</p><p>Aldenkamp A.P., Mulder O.G., Overweg J. Cognitive effects of lamotrigine as first line add-on in patients with localized related (partial) epilepsy. J Epilepsy 1997;10:117–21.</p><p>Ettinger A.B., Weisbrot D.M., Saracco J. et al. Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation. Epilepsia 1998;39:874–7.</p><p>Earl N., McKee J.R., Sunder T.R. et al. Lamotrigine adjunctive therapy in patients with refractory epilepsy and mental retardation [abstract]. Epilepsia 2000;41(Suppl 1):72(abst).</p><p>Aarts J.H., Binnie C.D., Smit A.M. et al. Selective cognitive impairment during focal and generalized epileptiform EEG activity. Brain 1984;107:293–308.</p><p>Aldenkamp A.P., Arends J., Overweg-Plandsoen T.C. et al. Acute cognitive effects of nonconvulsive difficult-to-detect epileptic seizures and epileptiform electroencephalographic discharges. J Child Neurol 2001;16:119–23.</p><p>Binnie C.D., van Emde B.W., Kasteleijn-Nolste-Trenite D.G. et al. Acute effects of lamotrigine (BW430C) in persons with epilepsy. Epilepsia 1986;27:248–54.</p><p>Marciani M.G., Spanedda F., Bassetti M.A. et al. Effect of lamotrigine on EEG paroxysmal abnormalities and background activity: a computerized analysis. Br J Clin Pharmacol 1996;42:621–7.</p><p>Marciani M.G., Stanzione P., Mattia D. et al. Lamotrigine add-on therapy in focal epilepsy: electroencephalographic and neuropsychological evaluation. Clin Neuropharmacol 1998;21:41–7.</p><p>Mervaala E., Koivista K., Hanninen T. et al. Electrophysiological and neuropsychological profiles of lamotrigine in young and age-associated memory impairment (AAMI) subjects [abstract]. Neurology 1995;45(Suppl 4):259(abst).</p><p>Helmstaedter C., Witt J.A. Cognitive outcome of antiepileptic treatment with levetiracetam versus carbamazepine monotherapy: a non-interventional surveillance trial. Epilepsy Behav 2010;18(1–2):74–80.</p><p>Lopez-Gongora M., Martinez-Domeno A., Garcia C., Escartin A. Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study. Epileptic Disord 2008;10(4):297–305.</p><p>Cho J.R., Koo D.L., Joo E.Y. et al. Effect of levetiracetam monotherapy on background EEG activity and cognition in drug-naïve epilepsy patients. Clin Neurophysiol 2012;123(5):883–91.</p><p>Schiemann-Delgado J., Yang H., Loge C. et al. A long-term open-label extension study assessing cognition and behaviour, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures. J Child Neurol 2012;27(1):80–9.</p><p>Meador K.J., Gevins A., Leese P.T. et al. Neurocognitive effects of brivaracetam, levetiracetam, and lorazepam. Epilepsia 2011;52(2):264–72.</p><p>Trimble M.R. Anticonvulsant drugs and cognitive function: a review of the literature. Epilepsia 1987;28(Suppl 3):37–45.</p><p>American Academy of Pediatrics. Behavioural and cognitive effects of anticonvulsant therapy. Committee on Drugs. Pediatrics 1985;76:644–7.</p></div><br />


Для цитирования:


Котов А.С. Влияние антиэпилептических препаратов на когнитивные функции. Неврология, нейропсихиатрия, психосоматика. 2013;5(1S):45-51. https://doi.org/10.14412/2074-2711-2013-2489

For citation:


Kotov A.S. The effect of antiepileptic drugs on cognitive functions. Neurology, Neuropsychiatry, Psychosomatics. 2013;5(1S):45-51. (In Russ.) https://doi.org/10.14412/2074-2711-2013-2489

Просмотров: 407


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)